Lexaria Bioscience Corp WT (NQ: LEXXW )
0.7500
-0.3600
(-32.43%)
Streaming Delayed Price
Updated: 12:09 PM EDT, May 2, 2024
Add to My Watchlist
Press Releases about Lexaria Bioscience Corp WT
Via ACCESSWIRE
Lexaria Awarded New Patents
April 02, 2024
Via ACCESSWIRE
Lexaria Unveils Extensive Planned 2024 GLP-1 Study Program
January 16, 2024
Via ACCESSWIRE
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer
March 14, 2024
Via ACCESSWIRE
Lexaria Awards Contract For Next GLP-1 Human Pilot Study
March 07, 2024
Via ACCESSWIRE
Via ACCESSWIRE
Via ACCESSWIRE
Lexaria's Submits Investigational New Drug Application
January 30, 2024
Via ACCESSWIRE
Lexaria Releases Annual Letter from the CEO
January 24, 2024
Via ACCESSWIRE
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program
January 16, 2024
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria's Investigational New Drug Application Filing Update
December 07, 2023
Via ACCESSWIRE
Lexaria Granted Two New Patents in Canada
October 12, 2023
Via ACCESSWIRE
Lexaria Announces Pricing of $1.6 Million Registered Direct Offering
September 29, 2023
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.